AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
The AACR is pleased to offer the Global Scholar-in-Training Awards (GSITA) to eligible early-career investigators in countries building cancer...
After a hiatus caused by the pandemic, Party with a Purpose, a cause-driven gala in Philadelphia that supports cancer...
By Nicholas Warren, PhD Today, the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology...
Cancer health disparities are driven by the compounding of multiple factors, including gaps in research resulting from insufficient representation...
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...
Guest post by Raymond N. DuBois, MD, PhD, FAACR The headlines stunned many medical professionals, cancer patients, and colorectal...
What is cancer, exactly? For the most part, experts agree. The National Cancer Institute defines cancer as “a disease...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
As we unpack our cardigans in anticipation of cooler weather here on the East Coast, we are taking a...
Guest post by Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH From November 7-9, 2022, Singapore will...